A behind the scenes look at Tuesday’s congressional hearing on #antimicrobialresistance .

Take action on the PASTEUR Act. Your voice will push Congress to create programs to help fight against AMR: idsociety.quorum.us/campaign/47463/

Senate HELP Committee GOP HELP Committee Dems Helen Boucher

Whatever area of focus, whatever stage in your career, you belong here. Join your colleagues Oct. 11-15 in Boston for #IDWeek2023 , the premier meeting for infectious diseases professionals.

Register: idweek.org/registration

Great work by Tessa Andermann and colleagues

“Resistance of Acinetobacter baumannii to the recently available cefiderocol is concerning. Sulbactam/durlobactam is a promising option for MDR A. baumannii”

Read the article by Tiseo et al:
doi.org/10.1093/jacamr…
OUP Medicine Oxford Journals #JACNews

Kakooza et al. report high prevalence of resistance to ciprofloxacin, tetracycline and benzylpenicillin, and emerging resistance determinants for azithromycin, in gonococcal isolates from African countries:

doi.org/10.1093/jac/dk…
OUP Medicine Oxford Journals #JACNews

In 2019, an estimated 1.27 million deaths worldwide were directly caused by AMR, and AMR played a part in nearly 5 million deaths. US healthcare costs linked to infections from six of the biggest AMR threats total more than $4.6 billion annually,  with $1.9 billion of these costs…

The deadline is fast approaching to submit your team for IDBugBowl, the Jeopardy-style quiz game you know and love.

Get your team together and submit your application by July 28: bit.ly/44wmRIo

ID BOARD REVIEW

45 YO M from Vietnam moved to the US 20 yrs ago s/p kidney Tx on tacrolimus & prednisone, c/o sudden headache & neck stiffness. LP done & CSF has 2000 WBC’s/mm3 (70% neutrophils), glucose of 10 mg/dl & gram stain has GNB’s. CSF Cx + for E.coli.

Empiric Rx is:

We are looking for PhD candidates🎓 to join our ERC Grant about the spread of antibiotic resistance. Dive into structural biology, biochemistry and microbiology in University of Geneva🇨🇭with cutting edge equipment for cryo-EM/ET and a beautifully place to work! please RT🔁

Long ago, the field of ID could have carved out paid niches in the interpretation of cultures, susceptibilities, etc. (like other specialties do). However, none of that happened and today the specialty can't attract sufficient fellows because other fields are more lucrative.

Nice work by Dylan Brown (starting Med school at ⁦Hofstra University⁩ in fall👍👍):
Socioeconomic disparities in the prevalence of multidrug resistance in Enterobacterales | Infection Control & Hospital Epidemiology | Cambridge Core
cambridge.org/core/journals/…

Welcome to our new UNC Division of Infectious Diseases fellows👍👍👍
@UNC UNC_ID_fellows_happyhour Institute for Global Health & Infectious Diseases

We’re pleased to share our latest impact metrics:
JAC-AMR was recently awarded a CiteScore™ (Scopus) of 3.8 & our first Impact Factor (Journal Citation Reports™) of 3.4
Thanks to all our authors, reviewers & Editors!
academic.oup.com/jacamr/pages/A…
BSAC David van Duin

WHO Global research agenda for antimicrobial resistance in human health who.int/publications/m…

Continuous infusion Meropenem did not improve outcome in Critically Ill Patients With Sepsis - double blind RCT jamanetwork.com/journals/jama/…

TxID Early Career Network Infectious Diseases Community of Practice - AST Ricardo M. La Hoz Ann Woolley This study looks to be quite well done; the authors say that “the results are not generalizable to patients who are immunocompromised”, in whom this can be a devastating, life-threatening infection. I have not had trouble giving four doses of ivermectin.